Update on the Role of Actovegin in Musculoskeletal Medicine: A Review of the Past 10 Years
Smith, Paul M.
Lee, Paul Y.F.
MetadataDangos cofnod eitem llawn
Background: Actovegin is a biological drug with a controversial history of use in the treatment of sports injuries during the past 60 years. Particular concerns have been raised about its ergogenic potential to enhance performance, but some of these have been based on little more than anecdote. Objectives: In this article, we review the most recent scientific evidence to determine the clinical efficacy, safety profile, and legal status of Actovegin. Methods: We considered all studies directly commenting on experience with Actovegin use as the primary intervention within the past 10 years. Outcomes included mechanisms of action, clinical efficacy in enhancing muscle repair, any report of safety issues, and any evidence for ergogenic effect. Results: Our database search returned 212 articles, abstracts were screened, and after inclusion/exclusion criteria were applied, 25 articles were considered: Publications included 11 primary research articles (7 in vitro studies and 4 clinical trials), 8 review articles, 5 editorials, and a single case report. Conclusions: Current literature is still yet to define the active compound(s) of Actovegin, but suggests that it shows antioxidant and antiapoptotic properties, and may also upregulate macrophage responses central to muscle repair. Clinical efficacy was supported by one new original research article, and the use of Actovegin to treat muscle injuries remains safe and supported. Two articles argued the ergogenic effect of Actovegin, but in vitro findings did not to translate to the outcomes of a clinical trial. An adequate and meaningful scientific approach remains difficult in a field where there is immense pressure to deliver cutting-edge therapies.
Clinical Journal of Sport Medicine;
Brock, J., Golding, D., Smith, P.M., Nokes, L., Kwan, A. and Lee, P.Y. (2018) 'Update on the Role of Actovegin in Musculoskeletal Medicine: A Review of the Past 10 Years', Clinical Journal of Sport Medicine: official journal of the Canadian Academy of Sport Medicine. doi: 10.1097/JSM.0000000000000566
Dynodwr Gwrthrych Digidol (DOI)https://doi.org/10.1097/JSM.0000000000000566
Article published in Clinical Journal of Sport Medicine, available ahead of print at https://doi.org/10.1097/JSM.0000000000000566
Cardiff Metropolitan University (Grant ID: Cardiff Metropolian (Internal))
- Sport Research Groups 
Yn dangos eitemau sy’n perthyn drwy deitl, awdur, pwnc a chrynodeb.
Lee, Paul; Kwan, Alvin; Smith, Paul M.; Nokes, Len (ECronicon Open Access, 2016-11-16)Actovegin is a biological drug produced from deproteinised hemodialysate of calf serum with over 50 years of history for its clinical use. There have been many in vitro studies to speculate its potential role and mechanism ...
Speech and Language Therapy students’ perceptions of parents who allow prolonged non-nutritive sucking and perceived consequences for the child. Harrop, Samantha (Cardiff Metropolitan University, 2011)Non-nutritive sucking (NNS) is reported to associate with impaired speech and language, recurrent otitis media, dental malformation and reduced success with breastfeeding. Potential benefits are often discarded, such as ...
'In search of ‘Omics'-based biomarkers to predict risk of frailty and its consequences in older individuals: the FRAILOMIC initiative Erusalimsky, Jorge; Grillari, Johannes; Grune, Tilman; Jansen-Duerr, Pidder; Lippi, Giuseppe; Sinclair, Alan; Tegner, Jesper; Vina, Jose; Durrance-Bagale, Anna; Minambres, Rebecca; Viegas, Marcelo; Rodriguez-Manas, Leocadio (Karger, 2016)An increase in the number of older people experiencing disability and dependence is a critical aspect of the demographic change that will emerge within Europe due to the rise in life expectancy. In this scenario, prevention ...